Deviating from safety guidelines during deferiprone therapy in clinical practice may not be associated with higher risk of agranulocytosis
Elalfy, Mohssen, Wali, Yasser A., Qari, Mohamad, Al Damanhouri, Ghazi, Al-Tonbary, Youssef, Yazman, Dilek, Al Hawsawi, Zakaria, Karakas, Zeynep, Kilinc, Yurdanur, Yesilipek, M. Akif, Badr, Mohamed, Elsafy, Usama, Salama, Mostafa, Abdel Rahman, Yousryeia, Shebl, Shebl, Stilman, Anne, Toiber Temin, Noemi, Tricta, Fernando
Published in Pediatric blood & cancer (01.05.2014)
Published in Pediatric blood & cancer (01.05.2014)
Get full text
Journal Article
Frequency of Agranulocytosis and Mild Neutropenia During Deferiprone Therapy in Clinical Practice
Elalfy, Mohsen Saleh, Shebl, Shebl Said, Badr, Mohamed A., Elsafy, Usama R., Salama, Mostafa A., Al-Tonbary, Youssef, Rahman, Yousryeia Abdel, Qari, Mohamad H., Al Damnhouri, Ghazi Abdullah, Al Hawsawi, Zakaria, Wali, Yasser Ahmed, Yesilipek, M. Akif, Kilinc, Yurdanur, Yazman, Dilek, Karakas, Zeynep, Tricta, Fernando
Published in Blood (16.11.2012)
Published in Blood (16.11.2012)
Get full text
Journal Article